Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Semaglutide: A Closer Look Semaglutide is primarily known as a GLP-1 receptor agonist, a drug class initially developed to treat type 2 diabetes by mimicking an intestinal hormone that helps control blood sugar
Acta 943, 2834
Annu Rev Physiol
They also work by slowing the rate of gastric emptying, or how long it takes for a meal to pass from your stomach to your intestines
UK Evidence Review Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK exclusively for treating type 2 diabetes mellitus in adults
Protocol Timeline See what to expect, week by week Protocol Timeline See what to expect, week by week Your protocol timeline What to expect, week by week Weeks 1-2 Nightly dosing before bed on an empty stomach
